1172796000: Product containing precisely linagliptin 2.5 milligram and metformin hydrochloride 500 milligram/1 each conventional release oral tablet (clinical drug)

• SNOMED CT Concept\Pharmaceutical / biologic product\Medicinal product\...
• \Medicinal product categorised by disposition\Enzyme inhibitor-containing product\Hydrolase inhibitor-containing product\Peptide hydrolase inhibitor-containing product\Dipeptidyl peptidase IV inhibitor-containing product\Linagliptin-containing product\...
• \Linagliptin-containing product in oral dose form\Linagliptin- and metformin-containing product in oral dose form\Linagliptin and metformin only product in oral dose form\Linagliptin 2.5 mg and metformin hydrochloride 500 mg oral tablet
• \Linagliptin- and metformin-containing product\Linagliptin and metformin only product\Linagliptin and metformin only product in oral dose form\Linagliptin 2.5 mg and metformin hydrochloride 500 mg oral tablet
• \Linagliptin- and metformin-containing product\Linagliptin- and metformin-containing product in oral dose form\Linagliptin and metformin only product in oral dose form\Linagliptin 2.5 mg and metformin hydrochloride 500 mg oral tablet
• \Medicinal product categorised by structure\Nitrogen and/or nitrogen compound-containing product\Linagliptin-containing product\Linagliptin-containing product in oral dose form\Linagliptin- and metformin-containing product in oral dose form\Linagliptin and metformin only product in oral dose form\Linagliptin 2.5 mg and metformin hydrochloride 500 mg oral tablet
• \Medicinal product categorised by structure\Nitrogen and/or nitrogen compound-containing product\Linagliptin-containing product\Linagliptin- and metformin-containing product\Linagliptin and metformin only product\Linagliptin and metformin only product in oral dose form\Linagliptin 2.5 mg and metformin hydrochloride 500 mg oral tablet
• \Medicinal product categorised by structure\Nitrogen and/or nitrogen compound-containing product\Linagliptin-containing product\Linagliptin- and metformin-containing product\Linagliptin- and metformin-containing product in oral dose form\Linagliptin and metformin only product in oral dose form\Linagliptin 2.5 mg and metformin hydrochloride 500 mg oral tablet
• \Medicinal product categorised by structure\Nitrogen and/or nitrogen compound-containing product\Biguanide-containing product\Metformin-containing product\Linagliptin- and metformin-containing product\Linagliptin and metformin only product\Linagliptin and metformin only product in oral dose form\Linagliptin 2.5 mg and metformin hydrochloride 500 mg oral tablet
• \Medicinal product categorised by structure\Nitrogen and/or nitrogen compound-containing product\Biguanide-containing product\Metformin-containing product\Linagliptin- and metformin-containing product\Linagliptin- and metformin-containing product in oral dose form\Linagliptin and metformin only product in oral dose form\Linagliptin 2.5 mg and metformin hydrochloride 500 mg oral tablet
• \Medicinal product categorised by structure\Nitrogen and/or nitrogen compound-containing product\Biguanide-containing product\Metformin-containing product\Metformin-containing product in oral dose form\Linagliptin- and metformin-containing product in oral dose form\Linagliptin and metformin only product in oral dose form\Linagliptin 2.5 mg and metformin hydrochloride 500 mg oral tablet
• \Medicinal product categorised by structure\Quinazoline-containing product\Linagliptin-containing product\Linagliptin-containing product in oral dose form\Linagliptin- and metformin-containing product in oral dose form\Linagliptin and metformin only product in oral dose form\Linagliptin 2.5 mg and metformin hydrochloride 500 mg oral tablet
• \Medicinal product categorised by structure\Quinazoline-containing product\Linagliptin-containing product\Linagliptin- and metformin-containing product\Linagliptin and metformin only product\Linagliptin and metformin only product in oral dose form\Linagliptin 2.5 mg and metformin hydrochloride 500 mg oral tablet
• \Medicinal product categorised by structure\Quinazoline-containing product\Linagliptin-containing product\Linagliptin- and metformin-containing product\Linagliptin- and metformin-containing product in oral dose form\Linagliptin and metformin only product in oral dose form\Linagliptin 2.5 mg and metformin hydrochloride 500 mg oral tablet
• \Product manufactured as oral dose form\Linagliptin-containing product in oral dose form\Linagliptin- and metformin-containing product in oral dose form\Linagliptin and metformin only product in oral dose form\Linagliptin 2.5 mg and metformin hydrochloride 500 mg oral tablet
• \Product manufactured as oral dose form\Metformin-containing product in oral dose form\Linagliptin- and metformin-containing product in oral dose form\Linagliptin and metformin only product in oral dose form\Linagliptin 2.5 mg and metformin hydrochloride 500 mg oral tablet

Status: current, Defined. Date: 30-Sep 2021. Module: SNOMED CT core

Descriptions:

Id	Description	Lang	Type	Status	Case?	Module
4636047014	Product containing precisely linagliptin 2.5 milligram and metformin hydrochloride 500 milligram/1 each conventional release oral tablet (clinical drug)	en	Fully specified name	Active	Case insensitive	SNOMED CT core
4636048016	Linagliptin 2.5 mg and metformin hydrochloride 500 mg oral tablet	en	Synonym	Active	Case insensitive	SNOMED CT core

Expanded Value Set

This concept is not in any reference sets

Back to Start